Relationship between baseline D-dimer and prognosis in Japanese patients with venous thromboembolism: Insights from the J'xactly study

被引:2
|
作者
Migita, Shohei [1 ]
Okumura, Yasuo [1 ]
Fukuda, Ikuo [2 ]
Nakamura, Mashio [3 ]
Yamada, Norikazu [4 ]
Takayama, Morimasa [5 ]
Maeda, Hideaki [6 ]
Yamashita, Takeshi [7 ]
Ikeda, Takanori [8 ]
Mo, Makoto [9 ]
Yamazaki, Tsutomu [10 ]
Hirayama, Atsushi [11 ]
机构
[1] Nihon Univ, Dept Med, Div Cardiol, Sch Med, Tokyo, Japan
[2] Keimeikai Yokawa Hosp, Dept Cardiol, Miki, Japan
[3] Nakamura Med Clin, Kuwana, Japan
[4] Kuwana City Med Ctr, Dept Cardiol, Kuwana, Japan
[5] Sakakibara Heart Inst, Dept Cardiol, Fuchu, Japan
[6] Ukima Cent Hosp, Vasc Ctr, Dept Heart, Tokyo, Japan
[7] Cardiovasc Inst, Dept Cardiovasc Med, Tokyo, Japan
[8] Toho Univ, Dept Cardiovasc Med, Fac Med, Tokyo, Japan
[9] Yokohama Minami Kyosai Hosp, Dept Cardiovasc Surg, Yokohama, Japan
[10] Int Univ Hlth & Welf, Innovat & Res Support Ctr, Tokyo, Japan
[11] Osaka Police Hosp, Dept Cardiol, Osaka, Japan
来源
关键词
anticoagulant; bleeding; recurrence; rivaroxaban; venous thromboembolism; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; ATRIAL-FIBRILLATION; MAJOR CONTRIBUTOR; MARKERS;
D O I
10.3389/fcvm.2023.1074661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: D-dimer is a biomarker of fibrin production and degradation, and changes in D-dimer concentration suggest fibrin clot formation, which is associated with thromboembolism and hypercoagulable states. Thus, an elevated D-dimer concentration could be a useful prognostic predictor for patients with venous thromboembolism (VTE).Methods and results: In this subanalysis of the J'xactly study, a prospective multicenter study conducted in Japan, we examined the clinical outcomes of 949 patients with VTE stratified by baseline D-dimer concentration. The median D-dimer concentration was 7.6 mu g/ml (low D-dimer group: n = 473, 49.8%]; high D-dimer group:>= 7.6 mu g/ml [n = 476, 50.2%]). The mean age of the patients was 68 years, and 386 patients (40.7%) were male. Compared with the low D-dimer group, the high D-dimer group had more frequent pulmonary embolism with or without deep vein thrombosis (DVT), proximal DVT, atrial fibrillation, or diabetes mellitus, and underwent intensive treatment with 30 mg/day rivaroxaban. The incidence of composite clinically relevant events (recurrence or exacerbation of symptomatic VTE, acute coronary syndrome [ACS], ischemic stroke, death from any cause, or major bleeding) was higher in the high D-dimer group than in the low D-dimer group (11.1% vs. 7.5% per patient-year; hazard ratio, 1.46; 95% confidence interval, 1.05-2.04; p = 0.025). There was no significant difference between the high and low D-dimer groups in the incidence of VTE (2.8% vs. 2.5% per patient-year, respectively; p = 0.788), ACS (0.4% per patient-year vs. not observed, respectively; p = 0.078), or major bleeding (4.0% vs. 2.1% per patient-year, respectively; p = 0.087), but there was a significant difference in the incidence of ischemic stroke (1.0% per patient-year vs. not observed, respectively; p = 0.004).Conclusion: Elevated D-dimer concentration may be an important prognostic predictor in Japanese patients with VTE.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism ― Insights From the J'xactly Study ―
    Yamashita, Takeshi
    Fukuda, Ikuo
    Nakamura, Mashio
    Yamada, Norikazu
    Takayama, Morimasa
    Maeda, Hideaki
    Ikeda, Takanori
    Mo, Makoto
    Yamazaki, Tsutomu
    Okumura, Yasuo
    Hirayama, Atsushi
    CIRCULATION REPORTS, 2022, 4 (08) : 371 - 377
  • [2] Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
    Shohei Migita
    Yasuo Okumura
    Ikuo Fukuda
    Mashio Nakamura
    Norikazu Yamada
    Morimasa Takayama
    Hideaki Maeda
    Takeshi Yamashita
    Takanori Ikeda
    Makoto Mo
    Tsutomu Yamazaki
    Atsushi Hirayama
    Thrombosis Journal, 21
  • [3] Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J'xactly study
    Migita, Shohei
    Okumura, Yasuo
    Fukuda, Ikuo
    Nakamura, Mashio
    Yamada, Norikazu
    Takayama, Morimasa
    Maeda, Hideaki
    Yamashita, Takeshi
    Ikeda, Takanori
    Mo, Makoto
    Yamazaki, Tsutomu
    Hirayama, Atsushi
    THROMBOSIS JOURNAL, 2023, 21 (01)
  • [4] Prognostic value of D-dimer in patients with venous thromboembolism
    Vorobyeva, N. M.
    Dobrovolsky, A. B.
    Titaeva, E., V
    Kirienko, A., I
    Panchenko, E. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 862 - 862
  • [5] D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study
    Palareti, Gualtiero
    Cosmi, Benilde
    Legnani, Cristina
    Antonucci, Emilia
    De Micheli, Valeria
    Ghirarduzzi, Angelo
    Poli, Daniela
    Testa, Sophie
    Tosetto, Alberto
    Pengo, Vittorio
    Prandoni, Paolo
    BLOOD, 2014, 124 (02) : 196 - 203
  • [6] The Role of D-dimer Testing in Patients with Suspected Venous Thromboembolism
    Prisco, Domenico
    Grifoni, Elisa
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (01): : 50 - 59
  • [7] The accuracy of D-dimer testing in patients with venous thromboembolism disease
    Adamek, L
    Nizankowska-Mogilnicka, E
    Domagala, TB
    Grzanka, P
    Sanak, M
    Szczeklik, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 250 - 250
  • [8] D-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism
    Palareti, Gualtiero
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (09) : 670 - 671
  • [9] Evaluation of a new automated quantitative d-dimer, Advanced D-Dimer, in patients suspected of venous thromboembolism
    Gosselin, RC
    Owings, JT
    Jacoby, RC
    Larkin, EC
    BLOOD COAGULATION & FIBRINOLYSIS, 2002, 13 (04) : 323 - 330
  • [10] Evaluation of a new automated quantitative D-dimer, advanced D-dimer, in patients suspected of venous thromboembolism: a comment on correlation of D-dimer assays
    Dempfle, CE
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (03) : 313 - 315